1. Home
  2. PTHL vs TETE Comparison

PTHL vs TETE Comparison

Compare PTHL & TETE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • TETE
  • Stock Information
  • Founded
  • PTHL 1998
  • TETE 2021
  • Country
  • PTHL China
  • TETE Malaysia
  • Employees
  • PTHL N/A
  • TETE N/A
  • Industry
  • PTHL
  • TETE Blank Checks
  • Sector
  • PTHL
  • TETE Finance
  • Exchange
  • PTHL Nasdaq
  • TETE Nasdaq
  • Market Cap
  • PTHL 65.0M
  • TETE 73.0M
  • IPO Year
  • PTHL 2024
  • TETE 2022
  • Fundamental
  • Price
  • PTHL $4.20
  • TETE $12.30
  • Analyst Decision
  • PTHL
  • TETE
  • Analyst Count
  • PTHL 0
  • TETE 0
  • Target Price
  • PTHL N/A
  • TETE N/A
  • AVG Volume (30 Days)
  • PTHL 56.3K
  • TETE 8.9K
  • Earning Date
  • PTHL 02-11-2025
  • TETE 01-01-0001
  • Dividend Yield
  • PTHL N/A
  • TETE N/A
  • EPS Growth
  • PTHL N/A
  • TETE N/A
  • EPS
  • PTHL N/A
  • TETE 0.02
  • Revenue
  • PTHL $572,291.00
  • TETE N/A
  • Revenue This Year
  • PTHL N/A
  • TETE N/A
  • Revenue Next Year
  • PTHL N/A
  • TETE N/A
  • P/E Ratio
  • PTHL N/A
  • TETE $699.42
  • Revenue Growth
  • PTHL 2.32
  • TETE N/A
  • 52 Week Low
  • PTHL $3.32
  • TETE $11.37
  • 52 Week High
  • PTHL $6.45
  • TETE $12.32
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • TETE 68.58
  • Support Level
  • PTHL N/A
  • TETE $12.21
  • Resistance Level
  • PTHL N/A
  • TETE $12.32
  • Average True Range (ATR)
  • PTHL 0.00
  • TETE 0.02
  • MACD
  • PTHL 0.00
  • TETE 0.01
  • Stochastic Oscillator
  • PTHL 0.00
  • TETE 84.62

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About TETE Technology & Telecommunication Acquisition Corporation

Technology & Telecommunication Acquisition Corp is a blank check company.

Share on Social Networks: